Rockwell Medical (RMTI) Assets Average (2011 - 2026)
Rockwell Medical (RMTI) posted Assets Average of $57.3 million for Q1 2026, little changed on a QoQ basis from $57.3 million in Q4 2025, and up 1.24% year-over-year from $56.6 million in Q1 2025.
Rockwell Medical (RMTI) Assets Average (2011 - 2026) Analysis & Trends
Rockwell Medical's Assets Average history runs 16 years deep, the most recent figure standing at $57.3 million for Q1 2026.
- Quarterly Assets Average rose 1.24% year-over-year to $57.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.3 million (up 1.24% YoY) and the FY2025 annual result came in at $58.2 million, up 4.46% from the prior year.
- Assets Average was $57.3 million for Q1 2026 at Rockwell Medical, roughly flat from $57.3 million in the prior quarter.
- Across five years, Assets Average topped out at $58.1 million in Q4 2024 and bottomed at $39.3 million in Q2 2023.
- A 5-year average of $51.5 million and a median of $52.4 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average sank 41.57% — and 2024, when it surged 32.15%.
- Rockwell Medical's Assets Average stood at $50.4 million in 2022, then advanced by 3.93% to $52.4 million in 2023, then climbed by 10.99% to $58.1 million in 2024, then dropped by 1.43% to $57.3 million in 2025, then retreated by 0.05% to $57.3 million in 2026.
- Business Quant data shows RMTI's Assets Average at $57.3 million in Q1 2026, $57.3 million in Q4 2025, and $55.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 57.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.28 Mn |
| Dec 31, 2025 | 57.32 Mn |
| Sep 30, 2025 | 55.06 Mn |
| Jun 30, 2025 | 53.29 Mn |
| Mar 31, 2025 | 56.58 Mn |
| Dec 31, 2024 | 58.15 Mn |
| Sep 30, 2024 | 55.06 Mn |
| Jun 30, 2024 | 51.88 Mn |
| Mar 31, 2024 | 51.45 Mn |
| Dec 31, 2023 | 52.39 Mn |
| Sep 30, 2023 | 45.32 Mn |
| Jun 30, 2023 | 39.25 Mn |
| Mar 31, 2023 | 43.55 Mn |
| Dec 31, 2022 | 50.41 Mn |
| Sep 30, 2022 | 56.65 Mn |
| Jun 30, 2022 | 48.28 Mn |
| Mar 31, 2022 | 43.01 Mn |
| Dec 31, 2021 | 53.64 Mn |
| Sep 30, 2021 | 61.19 Mn |
| Jun 30, 2021 | 66.57 Mn |